Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Aura Biosciences, Inc. (AURA) common stock is reported as beneficially owned in an amended report covering positions dated September 30, 2026. TCG Crossover Fund II, L.P. and its general partner, TCG Crossover GP II, LLC, each report 5,211,368 shares, or 5.0%. TCG Crossover Fund III, L.P. and its general partner, TCG Crossover GP III, LLC, each report 5,211,365 shares, or 5.0%. The reported amounts include common shares and 128,688 shares subject to pre-funded warrants exercisable within 60 days for each fund.
Chen Yu reports 10,422,733 shares, or 9.99%, through shared voting and dispositive power over the two funds’ positions. That amount includes 257,376 warrant shares exercisable within 60 days. An aggregate 3,542,624 additional warrant shares are excluded because they cannot be exercised within 60 days under a 9.99% beneficial ownership limitation. The share-count basis includes 104,074,302 common shares outstanding as of November 4, 2026.
Key Figures
Chen Yu reported beneficial ownership:10,422,733 sharesFund II reported beneficial ownership:5,211,368 sharesFund III reported beneficial ownership:5,211,365 shares+3 more
6 metrics
Chen Yu reported beneficial ownership10,422,733 shares9.99% of the class; includes shares held by TCG Crossover Fund II and Fund III
Fund II reported beneficial ownership5,211,368 shares5.0%; the fund and its general partner each report this amount
Fund III reported beneficial ownership5,211,365 shares5.0%; the fund and its general partner each report this amount
Common shares outstanding104,074,302 sharesAs of November 4, 2026, as reported by Aura Biosciences
Warrant shares exercisable within 60 days257,376 sharesAggregate held by the two funds and included in Chen Yu’s reported ownership
Warrant shares excluded from Chen Yu’s reported ownership3,542,624 sharesNot exercisable within 60 days due to the beneficial ownership limitation
"shares subject to Pre-Funded Warrants exercisable within 60 days"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Limitationregulatory
"may not be exercised to the extent that doing so would result"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared voting powerregulatory
"Shared Voting Power 10,422,733.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared Dispositive Power 10,422,733.00"
pecuniary interestregulatory
"except to the extent of such Reporting Person’s pecuniary interest therein"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many Aura Biosciences (AURA) shares does Chen Yu report beneficially owning?
Chen Yu reports beneficial ownership of 10,422,733 shares, or 9.99%, through shared voting and dispositive power over positions held by TCG Crossover Fund II and TCG Crossover Fund III. The reported total includes 257,376 shares subject to pre-funded warrants exercisable within 60 days.
What positions do TCG Crossover Fund II and Fund III report in AURA?
TCG Crossover Fund II, L.P. and its general partner each report 5,211,368 shares, or 5.0%; TCG Crossover Fund III, L.P. and its general partner each report 5,211,365 shares, or 5.0%. Each fund’s reported amount includes 128,688 shares subject to pre-funded warrants exercisable within 60 days.
Why are some AURA pre-funded warrant shares excluded from Chen Yu’s reported ownership?
An aggregate 3,542,624 warrant shares are excluded because they are not exercisable within 60 days under a limitation that prevents exercise if it would cause the holder, affiliates, and specified related persons to beneficially own more than 9.99% of the outstanding common stock.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Aura Biosciences, Inc.
(Name of Issuer)
Common Stock, par value $0.00001 per share
(Title of Class of Securities)
05153U107
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
05153U107
1
Names of Reporting Persons
TCG Crossover GP II, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,211,368.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,211,368.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,211,368.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.0 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Consists of (i) 5,082,680 shares of Common Stock and (ii) 128,688 shares of Common Stock subject to Pre-Funded Warrants (Pre-Funded Warrants) which are exercisable within 60 days of this Statement. These securities are held of record by TCG Crossover II (as defined in Item 2(a) below). TCG Crossover GP II (as defined in Item 2(a) below) is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. This total excludes 1,771,312 shares of Common Stock subject to Pre-Funded Warrants (the Pre-Funded Warrants) which are not exercisable within 60 days of this Statement because the Pre-Funded Warrants may not be exercised to the extent that doing so would result in the holder of the Pre-Funded Warrants and (together with the holder's affiliates and any other persons acting as a group together with the holder or any of the holder's affiliates) beneficially owning more than 9.99 percent of the shares of Common Stock then outstanding immediately after giving effect to such exercise (the Beneficial Ownership Limitation).
Based on 104,202,990, shares of Common Stock, as follows: (a) 104,074,302 outstanding as of November 4, 2026, as reported by the Issuer (as defined in Item 1(a) below) in its quarterly report filed with the Securities and Exchange Commission (the Commission) on November 9, 2026 (the Form 10-Q), plus (b) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement.
SCHEDULE 13G
CUSIP Number(s):
05153U107
1
Names of Reporting Persons
TCG Crossover Fund II, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,211,368.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,211,368.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,211,368.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.0 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Consists of (i) 5,082,680 shares of Common Stock and (ii) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement. These securities are held of record by TCG Crossover II. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. This total excludes 1,771,312 shares of Common Stock subject to Pre-Funded Warrants which are not exercisable within 60 days of this Statement due to the Beneficial Ownership Limitation.
Based on 104,202,990, shares of Common Stock, as follows: (a) 104,074,302 outstanding as of November 4, 2026, as reported by the Issuer in the Form 10-Q, plus (b) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement.
SCHEDULE 13G
CUSIP Number(s):
05153U107
1
Names of Reporting Persons
TCG Crossover GP III, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,211,365.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,211,365.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,211,365.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.0 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Consists of (i) 5,082,677 shares of Common Stock and (ii) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement. These securities are held of record by TCG Crossover III (as defined in Item 2(a) below). TCG Crossover GP III (as defined in Item 2(a) below) is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. This total excludes 1,771,312 shares of Common Stock subject to Pre-Funded Warrants which are not exercisable within 60 days of this Statement due to the Beneficial Ownership Limitation.
Based on 104,202,990, shares of Common Stock, as follows: (a) 104,074,302 outstanding as of November 4, 2026, as reported by the Issuer in the Form 10-Q, plus (b) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement.
SCHEDULE 13G
CUSIP Number(s):
05153U107
1
Names of Reporting Persons
TCG Crossover Fund III, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,211,365.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,211,365.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,211,365.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.0 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Consists of (i) 5,082,677 shares of Common Stock and (ii) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement. These securities are held of record by TCG Crossover III. TCG Crossover GP III is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. This total excludes 1,771,312 shares of Common Stock subject to Pre-Funded Warrants which are not exercisable within 60 days of this Statement due to the Beneficial Ownership Limitation.
Based on 104,202,990, shares of Common Stock, as follows: (a) 104,074,302 outstanding as of November 4, 2026, as reported by the Issuer in the Form 10-Q, plus (b) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement.
SCHEDULE 13G
CUSIP Number(s):
05153U107
1
Names of Reporting Persons
Chen Yu
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
10,422,733.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
10,422,733.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,422,733.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: Consists of (i) 5,082,680 shares of Common Stock held of record by TCG Crossover II, (ii) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement held of record by TCG Crossover II, (iii) 5,082,677 shares of Common Stock held of record by TCG Crossover III and (iv) 128,688 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement held of record by TCG Crossover III. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to the securities held of record by TCG Crossover II. TCG Crossover GP III is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to the securities held of record by TCG Crossover III. Chen Yu is the sole managing member of each of TCG Crossover GP II and TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to the securities held of record by TCG Crossover II and TCG Crossover III. This total excludes an aggregate of 3,542,624 shares of Common Stock subject to Pre-Funded Warrants held of record by TCG Crossover II and held of record by TCG Crossover III which are not exercisable within 60 days of this Statement due to the Beneficial Ownership Limitation.
Based on 104,331,678, shares of Common Stock, as follows: (a) 104,074,302 outstanding as of November 4, 2026, as reported by the Issuer in the Form 10-Q, plus (b) an aggregate of 257,376 shares of Common Stock subject to Pre-Funded Warrants which are exercisable within 60 days of this Statement held of record by TCG Crossover II and held of record by TCG Crossover III.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Aura Biosciences, Inc.
(b)
Address of issuer's principal executive offices:
80 Guest Street, Boston, MA 02135
Item 2.
(a)
Name of person filing:
This Amendment No. 1 (Amendment No. 1) amends and supplements the Schedule 13G initially filed with the Commission on May 12, 2026 (the Original Schedule 13G) and is being filed by TCG Crossover Fund II, L.P. (TCG Crossover II), TCG Crossover GP II, LLC (TCG Crossover GP II), TCG Crossover Fund III, L.P. (TCG Crossover III) and TCG Crossover GP III, LLC (TCG Crossover GP III and together with TCG Crossover II, TCG Crossover GP II and TCG Crossover III, the Reporting Entities) and Chen Yu (the Reporting Individual). The Reporting Entities and the Reporting Individual are collectively referred to as the Reporting Persons. The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13G. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached as Exhibit 1 to the Original Schedule 13G. Other than those securities reported herein as being held directly by such Reporting Person, each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein. Capitalized terms not defined in this Amendment No. 1 have the meanings ascribed to them in the Original Schedule 13G.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each Reporting Person is 245 Lytton Ave., Suite 350, Palo Alto, CA 94301.
(c)
Citizenship:
TCG Crossover GP II and TCG Crossover GP III are each a limited liability company organized under the laws of the State of Delaware. TCG Crossover II and TCG Crossover III are each a limited partnership organized under the laws of the State of Delaware. The Reporting Individual is a citizen of the United States of America.
(d)
Title of class of securities:
Common Stock, par value $0.00001 per share
(e)
CUSIP No.:
05153U107
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See Row 9 of the cover page for each Reporting Person and the corresponding comments.
(b)
Percent of class:
See Row 11 of the cover page for each Reporting Person and the corresponding comments.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Row 5 of the cover page for each Reporting Person and the corresponding comments.
(ii) Shared power to vote or to direct the vote:
See Row 6 of the cover page for each Reporting Person and the corresponding comments.
(iii) Sole power to dispose or to direct the disposition of:
See Row 7 of the cover page for each Reporting Person and the corresponding comments.
(iv) Shared power to dispose or to direct the disposition of:
See Row 8 of the cover page for each Reporting Person and the corresponding comments.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Under certain circumstances set forth in the limited partnership agreements of TCG Crossover II and TCG Crossover III and the limited liability company agreements of TCG Crossover GP II and TCG Crossover GP III, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of securities of the Issuer owned by each such entity of which they are a partner or member, as the case may be.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.